Chronic kidney disease causes an increase in serum potassium levels is associated with decreased renal ion excretion. Laxatives are used as medications to reduce the progression of CKD and hyperkalemia.
Keiichi Sumida, University of Tennessee Health Science Center, Memphis, Tennessee, and colleagues aimed to evaluate the effect of laxatives on chronic kidney disease patients to overcome hyperkalemia.
The study population encompassed 36,116 United States veterans transitioning to ESKD from 2007 to 2015 with greater than or equal to one plasma potassium measurement during the last 1-year period before ESKD transition. Using generalized estimating equations with adjustment for potential confounders, they examined the association of time-varying laxative use with risk of dyskalemia (i.e., hypokalemia [potassium <3.5 mEq/L] or hyperkalemia [>5.5 mEq/L]) versus normokalemia (3.5–5.5 mEq/L) over the 1-year pre-ESKD period. To avoid potential overestimation of dyskalemia risk, potassium measurements within 7 days following a dyskalemia event were disregarded in the analyses.
A total of 319,219 over the last one-year pre-ESKD period, there were repeated potassium measurements in the cohort study.
Out of these, it was found 12,787 (4.0%) represented hypokalemia, and 15,842 (5.0%) represented hyperkalemia; the time-averaged potassium measurement was 4.5 mEq/L.
The results of the study were:
• After multivariable adjustment, time-varying laxative use (compared with nonuse) was significantly associated with lower risk of hyperkalemia (adjusted odds ratio [aOR], 0.79)
• It was found that it was not associated with the risk of hypokalemia (aOR, 1.01). The results were robust to several sensitivity analyses.
Dr. Sumida and the team concluded that "Laxative use was independently associated with lower risk of hyperkalemia during the last 1-year pre-ESKD period. Our findings support a putative role of constipation in potassium disarrays and also support (with careful consideration for the risk-benefit profiles) the therapeutic potential of laxatives in hyperkalemia management in advanced CKD."
Reference:
The study titled, "Laxative Use and Risk of Dyskalemia in Patients with Advanced CKD Transitioning to Dialysis," is published in the Journal of the American Society of Nephrology.
DOI: https://jasn.asnjournals.org/content/32/4/950
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.